Design and Rationale of the Phase 2 Baricitinib Study in Apolipoprotein L1–Mediated Kidney Disease (JUSTICE)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Design and Rationale of the Phase 2 Baricitinib Study in Apolipoprotein L1–Mediated Kidney Disease (JUSTICE)

Published:2024-09 Issue:9 Volume:9 Page:2677-2684
ISSN:2468-0249
Container-title:Kidney International Reports
language:en
Short-container-title:Kidney International Reports

Author:

Olabisi Opeyemi A.,Barrett Nadine J.,Lucas Anika,Smith Maurice,Bethea Kenisha,Soldano Karen,Croall Stephanie,Sadeghpour Azita,Chakraborty Hrishikesh,Wolf Myles

Funder

NIMHD

Publisher

Elsevier BV

Reference41 articles.

1. US Renal Data System 2017 Annual Data Report: epidemiology of kidney disease in the United States;Saran;Am J Kidney Dis,2018

2. Residential structural racism and prevalence of chronic health conditions;Mohottige;JAMA Netw Open,2023

3. Association of trypanolytic APOL1 variants with kidney disease in African Americans;Genovese;Science,2010

4. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy;Kopp;J Am Soc Nephrol,2011

5. APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases;Olabisi;Proc Natl Acad Sci U S A,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP